🇺🇸 R115777 in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 14

Most-reported reactions

1. Asthenia — 2 reports (14.29%)
2. Blood Creatinine Increased — 2 reports (14.29%)
3. Dehydration — 2 reports (14.29%)
4. Fatigue — 2 reports (14.29%)
5. Abdominal Pain — 1 report (7.14%)
6. Anaemia — 1 report (7.14%)
7. Anorexia — 1 report (7.14%)
8. Blood Culture Positive — 1 report (7.14%)
9. Blood Lactate Dehydrogenase Increased — 1 report (7.14%)
10. C-Reactive Protein Increased — 1 report (7.14%)

Source database →

Frequently asked questions

Is R115777 approved in United States?

R115777 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for R115777 in United States?

SWOG Cancer Research Network is the originator. The local marketing authorisation holder may differ — check the official source linked above.